IP Verse

Boehringer Ingelheim vs. Zentiva Portugal - UPC_CFI_41/2025

The UPC Case UPC_CFI_41/2025 was filed on 22 Jan, 2025 by the plaintiff Boehringer Ingelheim against the defendant Zentiva Portugal.

Case Details

    Case Number:

    UPC_CFI_41/2025

    Patent Number:

    EP1830843

    Filing Date:

    22 Jan, 2025

    Proceeding Type:

    Provisionalmeasures

    Case Phase:

    Case Closed

    Plaintiffs:

    • Boehringer Ingelheim

    Plaintiff Representatives:

    • Joana PIRIQUITO SANTOS

    Defendants:

    • Zentiva Portugal

    Defendant Representatives:

    • Patricia PAIAS

    Judges:

    • Camille Lignieres
    • Petri Rinkinen
    • Rute Lopes

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
May 26, 2025Outcome Of The Order-
May 26, 2025Declaration
May 21, 2025Outcome Of The Order-
May 16, 2025Template Order
May 16, 2025Measures Decisionoutcome Notification-
May 16, 2025Declaration
May 8, 2025Final Order
Apr 22, 2025Request To The Registrar For The Recording Of The Oral Hearing To Be Made Available-
Apr 22, 2025Receipt-
Apr 16, 2025Template Order-
Apr 16, 2025Record-
Apr 16, 2025Receipt-
Apr 16, 2025Final Order Purposes
Apr 15, 2025Request Recording Oral Hearing-
Apr 10, 2025Response Under Order April 2,-
Apr 10, 2025Response Under App 15653-
Apr 9, 2025Receipt-
Apr 8, 2025Generic Procedural Appplication-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 5-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 4-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 3-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 2-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 1-
Apr 8, 2025Call For Proposals Under Framework Agreement (Reference:) Part 1-
Apr 8, 2025Call For Proposals Under Framework Agreement Part 4-
Apr 8, 2025Call For Proposals Under Framework Agreement Part 3-
Apr 8, 2025Call For Proposals Under Framework Agreement Part 2-
Apr 7, 2025Response Under Order Of April 2,-
Apr 7, 2025Response Under Order App 15653. Of April 2,-
Apr 7, 2025Receipt-
Apr 7, 2025Exhibit 27-
Apr 7, 2025Exhibit 26-
Apr 7, 2025Exhibit 2-
Apr 7, 2025Exhibit 1 Permanent Certificate-
Apr 7, 2025Exhibit 1-
Apr 7, 2025Applicant'S Note On Award Of Costs-
Apr 4, 2025Bi Reply To Zentiva Evidence Submission-
Apr 2, 2025Receipt-
Apr 2, 2025Order-
Mar 31, 2025Written Statement Ana Teixeira-
Mar 31, 2025Written Statement Ana Lopes-
Mar 31, 2025Receipt-
Mar 31, 2025Order-
Mar 31, 2025Exhibit 25 Defence Spms-
Mar 31, 2025Exhibit 24 Defence Zentiva-
Mar 31, 2025Exhibit 23 Article Prof. Marco Caldeira-
Mar 31, 2025Exhibit 22 Zentiva Atos Societarios-
Mar 31, 2025Exhibit 21 Declaration Manuela Kreuder-
Mar 31, 2025Exhibit 20 Declaration Vanessa Jacinto-
Mar 31, 2025Application Written-
Mar 31, 2025Application For Written Witnesses Statements-
Mar 28, 2025Generic Procedural Appplication-
Mar 28, 2025Exhibit 1 Tpi Decision-
Mar 24, 2025Receipt-
Mar 21, 2025Rejoinder-
Mar 21, 2025Exhibit 4 Order 1771 B 2016-
Mar 21, 2025Exhibit 3 Decree Law 19 2010-
Mar 21, 2025Exhibit 2 Order 55 2013-
Mar 21, 2025Exhibit 1 Proof Of Judicial Certificate-
Mar 13, 2025Receipt-
Mar 12, 2025Reply To The Objection-
Mar 12, 2025Exhibit 19-
Mar 12, 2025Exhibit 18-
Mar 12, 2025Exhibit 17-
Mar 7, 2025Request Remit To Objection Filed 03.03-
Mar 7, 2025Acknowledgement Of Lodging-
Mar 6, 2025Summon Oral Hearing-
Mar 6, 2025Order
Mar 3, 2025Template Order-
Mar 3, 2025Receipt-
Mar 3, 2025Order 209.1(B) Rop
Mar 3, 2025Oral Hearing-
Mar 3, 2025Objection Provisional Measures Application-
Mar 3, 2025Exhibit 5 Clarification Boehringer Ingelheim Portugal 30.01-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 4-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 3-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 2-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 1-
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 3-
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 2-
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 1-
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb Part 3-
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb Part 2-
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb (I)-
Mar 3, 2025Exhibit 1 Certificate Spc 679-
Feb 24, 2025Acknowledgement Of Access To Case-
Feb 10, 2025Receipt Confirmation-
Feb 10, 2025Notification Of Service-
Jan 30, 2025Letter For Service-
Jan 29, 2025Template Order-
Jan 29, 2025Preliminary Order R-
Jan 29, 2025Panel Appointment-
Jan 23, 2025Response To The Request For Amendments-
Jan 23, 2025Proof Of Payment Of Court Fees-
Jan 23, 2025Formal Checks Notification Of Positive Outcome-
Jan 23, 2025Exhibit 9 Zentiva Generics Mas: Infomed Extract (Pt And Eng)-
Jan 23, 2025Exhibit 8 Decision Of China National Intellectual Property Administration-
Jan 23, 2025Exhibit 7 Decision Of The Federal Court Of Canada-
Jan 23, 2025Exhibit 6 EP1830843B1 Decision Of The Od Of The Epo-
Jan 23, 2025Exhibit 5 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorization-
Jan 23, 2025Exhibit 4 EP1830843B1 Epo Registrar And National Registrars-
Jan 23, 2025Exhibit 3 EP1830843B1-
Jan 23, 2025Exhibit 2 Ofev Summary Of Product Characteristics And Package Leaflet-
Jan 23, 2025Exhibit 1 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorized Boehringer Ingelheim International Gmbh To File To Proc-
Jan 23, 2025Exhibit 16 Written Statement From Mariana Nascimento-
Jan 23, 2025Exhibit 15 Iqvia Data-
Jan 23, 2025Exhibit 14 EP1830843B1Opt Out And Withdrawal Of The Opt Out-
Jan 23, 2025Exhibit 13 Notice No. (Pt And En)-
Jan 23, 2025Exhibit 12 Zentiva Generics Smpc And Pl (Pt And En)-
Jan 23, 2025Exhibit 11 Zentiva: Authorised And Registered Wholesale Distributor Of Medicines-
Jan 23, 2025Exhibit 10 Zentiva Generics: Dcp Procedure-
Jan 23, 2025Application For Provisional Measures-
Jan 23, 2025Application For Measures Receipt-
Jan 22, 2025Formal Checks Request For Correction-
Jan 21, 2025Proof Of Payment Of Court Fees-
Jan 21, 2025Exhibit 9 Zentiva Generics Mas: Infomed Extract (Pt And Eng)-
Jan 21, 2025Exhibit 8 Decision Of China National Intellectual Property Administration-
Jan 21, 2025Exhibit 7 Decision Of The Federal Court Of Canada-
Jan 21, 2025Exhibit 6 EP1830843B1 Decision Of The Od Of The Epo-
Jan 21, 2025Exhibit 5 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorization-
Jan 21, 2025Exhibit 4 EP1830843B1 Epo Registrar And National Registrars-
Jan 21, 2025Exhibit 3 EP1830843B1-
Jan 21, 2025Exhibit 2 Ofev Summary Of Product Characteristics And Package Leaflet-
Jan 21, 2025Exhibit 1 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorized Boehringer Ingelheim International Gmbh To File To Proc-
Jan 21, 2025Exhibit 16 Written Statement From Mariana Nascimento-
Jan 21, 2025Exhibit 15 Iqvia Data-
Jan 21, 2025Exhibit 14 EP1830843B1Opt Out And Withdrawal Of The Opt Out-
Jan 21, 2025Exhibit 13 Notice No. (Pt And En)-
Jan 21, 2025Exhibit 12 Zentiva Generics Smpc And Pl (Pt And En)-
Jan 21, 2025Exhibit 11 Zentiva: Authorised And Registered Wholesale Distributor Of Medicines-
Jan 21, 2025Exhibit 10 Zentiva Generics: Dcp Procedure-
Jan 21, 2025Application For Provisional Measures-
Jan 21, 2025Application For Measures Acknowledgement-
May 26, 2025Outcome Of The Order-
May 26, 2025Declaration
May 21, 2025Outcome Of The Order-
May 16, 2025Template Order
May 16, 2025Measures Decisionoutcome Notification-
May 16, 2025Declaration
May 8, 2025Final Order
Apr 22, 2025Request To The Registrar For The Recording Of The Oral Hearing To Be Made Available-
Apr 22, 2025Receipt-
Apr 16, 2025Template Order-
Apr 16, 2025Record-
Apr 16, 2025Receipt-
Apr 16, 2025Final Order Purposes
Apr 15, 2025Request Recording Oral Hearing-
Apr 10, 2025Response Under Order April 2,-
Apr 10, 2025Response Under App 15653-
Apr 9, 2025Receipt-
Apr 8, 2025Generic Procedural Appplication-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 5-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 4-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 3-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 2-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 1-
Apr 8, 2025Call For Proposals Under Framework Agreement (Reference:) Part 1-
Apr 8, 2025Call For Proposals Under Framework Agreement Part 4-
Apr 8, 2025Call For Proposals Under Framework Agreement Part 3-
Apr 8, 2025Call For Proposals Under Framework Agreement Part 2-
Apr 7, 2025Response Under Order Of April 2,-
Apr 7, 2025Response Under Order App 15653. Of April 2,-
Apr 7, 2025Receipt-
Apr 7, 2025Exhibit 27-
Apr 7, 2025Exhibit 26-
Apr 7, 2025Exhibit 2-
Apr 7, 2025Exhibit 1 Permanent Certificate-
Apr 7, 2025Exhibit 1-
Apr 7, 2025Applicant'S Note On Award Of Costs-
Apr 4, 2025Bi Reply To Zentiva Evidence Submission-
Apr 2, 2025Receipt-
Apr 2, 2025Order-
Mar 31, 2025Written Statement Ana Teixeira-
Mar 31, 2025Written Statement Ana Lopes-
Mar 31, 2025Receipt-
Mar 31, 2025Order-
Mar 31, 2025Exhibit 25 Defence Spms-
Mar 31, 2025Exhibit 24 Defence Zentiva-
Mar 31, 2025Exhibit 23 Article Prof. Marco Caldeira-
Mar 31, 2025Exhibit 22 Zentiva Atos Societarios-
Mar 31, 2025Exhibit 21 Declaration Manuela Kreuder-
Mar 31, 2025Exhibit 20 Declaration Vanessa Jacinto-
Mar 31, 2025Application Written-
Mar 31, 2025Application For Written Witnesses Statements-
Mar 28, 2025Generic Procedural Appplication-
Mar 28, 2025Exhibit 1 Tpi Decision-
Mar 24, 2025Receipt-
Mar 21, 2025Rejoinder-
Mar 21, 2025Exhibit 4 Order 1771 B 2016-
Mar 21, 2025Exhibit 3 Decree Law 19 2010-
Mar 21, 2025Exhibit 2 Order 55 2013-
Mar 21, 2025Exhibit 1 Proof Of Judicial Certificate-
Mar 13, 2025Receipt-
Mar 12, 2025Reply To The Objection-
Mar 12, 2025Exhibit 19-
Mar 12, 2025Exhibit 18-
Mar 12, 2025Exhibit 17-
Mar 7, 2025Request Remit To Objection Filed 03.03-
Mar 7, 2025Acknowledgement Of Lodging-
Mar 6, 2025Summon Oral Hearing-
Mar 6, 2025Order
Mar 3, 2025Template Order-
Mar 3, 2025Receipt-
Mar 3, 2025Order 209.1(B) Rop
Mar 3, 2025Oral Hearing-
Mar 3, 2025Objection Provisional Measures Application-
Mar 3, 2025Exhibit 5 Clarification Boehringer Ingelheim Portugal 30.01-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 4-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 3-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 2-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 1-
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 3-
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 2-
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 1-
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb Part 3-
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb Part 2-
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb (I)-
Mar 3, 2025Exhibit 1 Certificate Spc 679-
Feb 24, 2025Acknowledgement Of Access To Case-
Feb 10, 2025Receipt Confirmation-
Feb 10, 2025Notification Of Service-
Jan 30, 2025Letter For Service-
Jan 29, 2025Template Order-
Jan 29, 2025Preliminary Order R-
Jan 29, 2025Panel Appointment-
Jan 23, 2025Response To The Request For Amendments-
Jan 23, 2025Proof Of Payment Of Court Fees-
Jan 23, 2025Formal Checks Notification Of Positive Outcome-
Jan 23, 2025Exhibit 9 Zentiva Generics Mas: Infomed Extract (Pt And Eng)-
Jan 23, 2025Exhibit 8 Decision Of China National Intellectual Property Administration-
Jan 23, 2025Exhibit 7 Decision Of The Federal Court Of Canada-
Jan 23, 2025Exhibit 6 EP1830843B1 Decision Of The Od Of The Epo-
Jan 23, 2025Exhibit 5 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorization-
Jan 23, 2025Exhibit 4 EP1830843B1 Epo Registrar And National Registrars-
Jan 23, 2025Exhibit 3 EP1830843B1-
Jan 23, 2025Exhibit 2 Ofev Summary Of Product Characteristics And Package Leaflet-
Jan 23, 2025Exhibit 1 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorized Boehringer Ingelheim International Gmbh To File To Proc-
Jan 23, 2025Exhibit 16 Written Statement From Mariana Nascimento-
Jan 23, 2025Exhibit 15 Iqvia Data-
Jan 23, 2025Exhibit 14 EP1830843B1Opt Out And Withdrawal Of The Opt Out-
Jan 23, 2025Exhibit 13 Notice No. (Pt And En)-
Jan 23, 2025Exhibit 12 Zentiva Generics Smpc And Pl (Pt And En)-
Jan 23, 2025Exhibit 11 Zentiva: Authorised And Registered Wholesale Distributor Of Medicines-
Jan 23, 2025Exhibit 10 Zentiva Generics: Dcp Procedure-
Jan 23, 2025Application For Provisional Measures-
Jan 23, 2025Application For Measures Receipt-
Jan 22, 2025Formal Checks Request For Correction-
Jan 21, 2025Proof Of Payment Of Court Fees-
Jan 21, 2025Exhibit 9 Zentiva Generics Mas: Infomed Extract (Pt And Eng)-
Jan 21, 2025Exhibit 8 Decision Of China National Intellectual Property Administration-
Jan 21, 2025Exhibit 7 Decision Of The Federal Court Of Canada-
Jan 21, 2025Exhibit 6 EP1830843B1 Decision Of The Od Of The Epo-
Jan 21, 2025Exhibit 5 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorization-
Jan 21, 2025Exhibit 4 EP1830843B1 Epo Registrar And National Registrars-
Jan 21, 2025Exhibit 3 EP1830843B1-
Jan 21, 2025Exhibit 2 Ofev Summary Of Product Characteristics And Package Leaflet-
Jan 21, 2025Exhibit 1 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorized Boehringer Ingelheim International Gmbh To File To Proc-
Jan 21, 2025Exhibit 16 Written Statement From Mariana Nascimento-
Jan 21, 2025Exhibit 15 Iqvia Data-
Jan 21, 2025Exhibit 14 EP1830843B1Opt Out And Withdrawal Of The Opt Out-
Jan 21, 2025Exhibit 13 Notice No. (Pt And En)-
Jan 21, 2025Exhibit 12 Zentiva Generics Smpc And Pl (Pt And En)-
Jan 21, 2025Exhibit 11 Zentiva: Authorised And Registered Wholesale Distributor Of Medicines-
Jan 21, 2025Exhibit 10 Zentiva Generics: Dcp Procedure-
Jan 21, 2025Application For Provisional Measures-
Jan 21, 2025Application For Measures Acknowledgement-
May 26, 2025Outcome Of The Order-
May 26, 2025Declaration
May 21, 2025Outcome Of The Order-
May 16, 2025Template Order
May 16, 2025Measures Decisionoutcome Notification-
May 16, 2025Declaration
May 8, 2025Final Order
Apr 22, 2025Request To The Registrar For The Recording Of The Oral Hearing To Be Made Available-
Apr 22, 2025Receipt-
Apr 16, 2025Template Order-
Apr 16, 2025Record-
Apr 16, 2025Receipt-
Apr 16, 2025Final Order Purposes
Apr 15, 2025Request Recording Oral Hearing-
Apr 10, 2025Response Under Order April 2,-
Apr 10, 2025Response Under App 15653-
Apr 9, 2025Receipt-
Apr 8, 2025Generic Procedural Appplication-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 5-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 4-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 3-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 2-
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 1-
Apr 8, 2025Call For Proposals Under Framework Agreement (Reference:) Part 1-
Apr 8, 2025Call For Proposals Under Framework Agreement Part 4-
Apr 8, 2025Call For Proposals Under Framework Agreement Part 3-
Apr 8, 2025Call For Proposals Under Framework Agreement Part 2-
Apr 7, 2025Response Under Order Of April 2,-
Apr 7, 2025Response Under Order App 15653. Of April 2,-
Apr 7, 2025Receipt-
Apr 7, 2025Exhibit 27-
Apr 7, 2025Exhibit 26-
Apr 7, 2025Exhibit 2-
Apr 7, 2025Exhibit 1 Permanent Certificate-
Apr 7, 2025Exhibit 1-
Apr 7, 2025Applicant'S Note On Award Of Costs-
Apr 4, 2025Bi Reply To Zentiva Evidence Submission-
Apr 2, 2025Receipt-
Apr 2, 2025Order-
Mar 31, 2025Written Statement Ana Teixeira-
Mar 31, 2025Written Statement Ana Lopes-
Mar 31, 2025Receipt-
Mar 31, 2025Order-
Mar 31, 2025Exhibit 25 Defence Spms-
Mar 31, 2025Exhibit 24 Defence Zentiva-
Mar 31, 2025Exhibit 23 Article Prof. Marco Caldeira-
Mar 31, 2025Exhibit 22 Zentiva Atos Societarios-
Mar 31, 2025Exhibit 21 Declaration Manuela Kreuder-
Mar 31, 2025Exhibit 20 Declaration Vanessa Jacinto-
Mar 31, 2025Application Written-
Mar 31, 2025Application For Written Witnesses Statements-
Mar 28, 2025Generic Procedural Appplication-
Mar 28, 2025Exhibit 1 Tpi Decision-
Mar 24, 2025Receipt-
Mar 21, 2025Rejoinder-
Mar 21, 2025Exhibit 4 Order 1771 B 2016-
Mar 21, 2025Exhibit 3 Decree Law 19 2010-
Mar 21, 2025Exhibit 2 Order 55 2013-
Mar 21, 2025Exhibit 1 Proof Of Judicial Certificate-
Mar 13, 2025Receipt-
Mar 12, 2025Reply To The Objection-
Mar 12, 2025Exhibit 19-
Mar 12, 2025Exhibit 18-
Mar 12, 2025Exhibit 17-
Mar 7, 2025Request Remit To Objection Filed 03.03-
Mar 7, 2025Acknowledgement Of Lodging-
Mar 6, 2025Summon Oral Hearing-
Mar 6, 2025Order
Mar 3, 2025Template Order-
Mar 3, 2025Receipt-
Mar 3, 2025Order 209.1(B) Rop
Mar 3, 2025Oral Hearing-
Mar 3, 2025Objection Provisional Measures Application-
Mar 3, 2025Exhibit 5 Clarification Boehringer Ingelheim Portugal 30.01-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 4-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 3-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 2-
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 1-
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 3-
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 2-
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 1-
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb Part 3-
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb Part 2-
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb (I)-
Mar 3, 2025Exhibit 1 Certificate Spc 679-
Feb 24, 2025Acknowledgement Of Access To Case-
Feb 10, 2025Receipt Confirmation-
Feb 10, 2025Notification Of Service-
Jan 30, 2025Letter For Service-
Jan 29, 2025Template Order-
Jan 29, 2025Preliminary Order R-
Jan 29, 2025Panel Appointment-
Jan 23, 2025Response To The Request For Amendments-
Jan 23, 2025Proof Of Payment Of Court Fees-
Jan 23, 2025Formal Checks Notification Of Positive Outcome-
Jan 23, 2025Exhibit 9 Zentiva Generics Mas: Infomed Extract (Pt And Eng)-
Jan 23, 2025Exhibit 8 Decision Of China National Intellectual Property Administration-
Jan 23, 2025Exhibit 7 Decision Of The Federal Court Of Canada-
Jan 23, 2025Exhibit 6 EP1830843B1 Decision Of The Od Of The Epo-
Jan 23, 2025Exhibit 5 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorization-
Jan 23, 2025Exhibit 4 EP1830843B1 Epo Registrar And National Registrars-
Jan 23, 2025Exhibit 3 EP1830843B1-
Jan 23, 2025Exhibit 2 Ofev Summary Of Product Characteristics And Package Leaflet-
Jan 23, 2025Exhibit 1 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorized Boehringer Ingelheim International Gmbh To File To Proc-
Jan 23, 2025Exhibit 16 Written Statement From Mariana Nascimento-
Jan 23, 2025Exhibit 15 Iqvia Data-
Jan 23, 2025Exhibit 14 EP1830843B1Opt Out And Withdrawal Of The Opt Out-
Jan 23, 2025Exhibit 13 Notice No. (Pt And En)-
Jan 23, 2025Exhibit 12 Zentiva Generics Smpc And Pl (Pt And En)-
Jan 23, 2025Exhibit 11 Zentiva: Authorised And Registered Wholesale Distributor Of Medicines-
Jan 23, 2025Exhibit 10 Zentiva Generics: Dcp Procedure-
Jan 23, 2025Application For Provisional Measures-
Jan 23, 2025Application For Measures Receipt-
Jan 22, 2025Formal Checks Request For Correction-
Jan 21, 2025Proof Of Payment Of Court Fees-
Jan 21, 2025Exhibit 9 Zentiva Generics Mas: Infomed Extract (Pt And Eng)-
Jan 21, 2025Exhibit 8 Decision Of China National Intellectual Property Administration-
Jan 21, 2025Exhibit 7 Decision Of The Federal Court Of Canada-
Jan 21, 2025Exhibit 6 EP1830843B1 Decision Of The Od Of The Epo-
Jan 21, 2025Exhibit 5 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorization-
Jan 21, 2025Exhibit 4 EP1830843B1 Epo Registrar And National Registrars-
Jan 21, 2025Exhibit 3 EP1830843B1-
Jan 21, 2025Exhibit 2 Ofev Summary Of Product Characteristics And Package Leaflet-
Jan 21, 2025Exhibit 1 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorized Boehringer Ingelheim International Gmbh To File To Proc-
Jan 21, 2025Exhibit 16 Written Statement From Mariana Nascimento-
Jan 21, 2025Exhibit 15 Iqvia Data-
Jan 21, 2025Exhibit 14 EP1830843B1Opt Out And Withdrawal Of The Opt Out-
Jan 21, 2025Exhibit 13 Notice No. (Pt And En)-
Jan 21, 2025Exhibit 12 Zentiva Generics Smpc And Pl (Pt And En)-
Jan 21, 2025Exhibit 11 Zentiva: Authorised And Registered Wholesale Distributor Of Medicines-
Jan 21, 2025Exhibit 10 Zentiva Generics: Dcp Procedure-
Jan 21, 2025Application For Provisional Measures-
Jan 21, 2025Application For Measures Acknowledgement-

More cases involving EP1830843B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_24205/2025May 23, 2025Boehringer IngelheimZentiva Portugal
UPC_COA_446/2025May 23, 2025Boehringer IngelheimZentiva Portugal
ACT_3186/2025Jan 22, 2025Boehringer IngelheimZentiva Portugal

More cases involving Boehringer Ingelheim

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_33288/2025Jul 21, 2025Boehringer Ingelheim -
APL_24205/2025May 23, 2025Boehringer IngelheimZentiva Portugal
UPC_COA_446/2025May 23, 2025Boehringer IngelheimZentiva Portugal

More cases involving Zentiva Portugal

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_24205/2025May 23, 2025Boehringer IngelheimZentiva Portugal
UPC_COA_446/2025May 23, 2025Boehringer IngelheimZentiva Portugal
ORD_24048/2025May 20, 2025NovartisZentiva Portugal